RNA virus quasispecies: Significance for viral disease and epidemiology

E. A. Duarte, I. S. Novella, Scott Weaver, E. Domingo, S. Wain-Hobson, D. K. Clarke, A. Moya, S. F. Elena, J. C. De la Torre, J. J. Holland

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

The experimental evidence available for animal and plant RNA viruses, as well as other RNA genetic elements (viroids, satellites, retroelements, etc.), reinforces the view that many different types of genetic alterations may occur during RNA genome replication. This is fundamentally because of infidelity of genome replication and large population sizes. Homologous and heterologous recombination, as well as gene reassortments occur frequently during replication of retroviruses and most riboviruses, especially those that use enzymes with limited processivity. Following the generation of variant genomes, selection, which is dependent on environmental parameters in ways that are poorly understood, sorts out those genome fits enough to generate viable quasispecies. Chance events can also be destabilizing, as illustrated by recent results on fitness loss and other phenotypic changes accompanying bottleneck transmission. Variation, selection, and random sampling of genomes occur continuously and unavoidably during virus evolution. Evolution of RNA viruses is largely unpredictable because of the stochastic nature of mutation and recombination events, as well as the subtle effects of chance transmission events and host/environmental factors. Among environmental factors, alterations resulting from human intervention (deforestation, agricultural activities, global climatic changes, etc.) may alter dispersal patterns and provide new adaptive possibilities to viral quasispecies. Current understanding of RNA virus evolution suggests several strategies to control and diagnose viral diseases. The new generation of chemically defined vaccines and diagnostic reagents (monoclonal antibodies, peptide antigens, oligonucleotides for polymerase chain reaction amplification, etc.) may be adequate to prevent disease and detect some or even most of the circulating quasispecies of any given RNA pathogen. However, the dynamics of viral quasispecies mandate careful consideration of those reagents to be incorporated into diagnostic kits. Broadening diagnosis without jeopardizing specificity of detection will be challenging. There is a finite probability (impossible to quantify at present) that a defined vaccine may promote selection of escape mutants or a particular diagnostic kit may fail to detect a viral pathogen. Of particular concern are the potential long-term effects of weak selective pressures that may initially go unnoticed. Variant viruses resulting from evolutionary pressure imposed by vaccines or drugs may insidiously and gradually replace previous quasispecies. The great potential for variation and phenotypic diversity of some important RNA virus pathogens (human immunodeficiency virus, the hepatitis viruses, the newly recognized human hantaviruses, etc.) has become clear. Prevention and therapy should rely on multicomponent vaccines and antiviral agents to address the complexity of RNA quasispecies mutant spectra. This will require additional vaccine antigens and larger repertoires of drugs directed at multiple viral targets. Finally, new avenues of research, such as molecular approaches to promote error catastrophe during viral replication, should also be undertaken. Basic studies on quasispecies and on population genetics of RNA viruses are justified not only by their relevance to the understanding of viral evolution but also by their direct implications for viral pathogenesis and for strategies of disease control.

Original languageEnglish
Pages (from-to)201-214
Number of pages14
JournalInfectious Agents and Disease
Volume3
Issue number4
StatePublished - 1994
Externally publishedYes

Fingerprint

RNA Viruses
Virus Diseases
Epidemiology
Vaccines
Genome
RNA
Viroids
Plant RNA
Hantavirus
Viruses
Antigens
Plant Viruses
Hepatitis Viruses
Retroelements
Homologous Recombination
Conservation of Natural Resources
Population Genetics
Retroviridae
Population Density
Pharmaceutical Preparations

Keywords

  • Diagnosis
  • Disease
  • Drug
  • Evolution
  • Quasispecies
  • RNA virus
  • Vaccine

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Duarte, E. A., Novella, I. S., Weaver, S., Domingo, E., Wain-Hobson, S., Clarke, D. K., ... Holland, J. J. (1994). RNA virus quasispecies: Significance for viral disease and epidemiology. Infectious Agents and Disease, 3(4), 201-214.

RNA virus quasispecies : Significance for viral disease and epidemiology. / Duarte, E. A.; Novella, I. S.; Weaver, Scott; Domingo, E.; Wain-Hobson, S.; Clarke, D. K.; Moya, A.; Elena, S. F.; De la Torre, J. C.; Holland, J. J.

In: Infectious Agents and Disease, Vol. 3, No. 4, 1994, p. 201-214.

Research output: Contribution to journalArticle

Duarte, EA, Novella, IS, Weaver, S, Domingo, E, Wain-Hobson, S, Clarke, DK, Moya, A, Elena, SF, De la Torre, JC & Holland, JJ 1994, 'RNA virus quasispecies: Significance for viral disease and epidemiology', Infectious Agents and Disease, vol. 3, no. 4, pp. 201-214.
Duarte EA, Novella IS, Weaver S, Domingo E, Wain-Hobson S, Clarke DK et al. RNA virus quasispecies: Significance for viral disease and epidemiology. Infectious Agents and Disease. 1994;3(4):201-214.
Duarte, E. A. ; Novella, I. S. ; Weaver, Scott ; Domingo, E. ; Wain-Hobson, S. ; Clarke, D. K. ; Moya, A. ; Elena, S. F. ; De la Torre, J. C. ; Holland, J. J. / RNA virus quasispecies : Significance for viral disease and epidemiology. In: Infectious Agents and Disease. 1994 ; Vol. 3, No. 4. pp. 201-214.
@article{e18d74064e484174a749268072a98135,
title = "RNA virus quasispecies: Significance for viral disease and epidemiology",
abstract = "The experimental evidence available for animal and plant RNA viruses, as well as other RNA genetic elements (viroids, satellites, retroelements, etc.), reinforces the view that many different types of genetic alterations may occur during RNA genome replication. This is fundamentally because of infidelity of genome replication and large population sizes. Homologous and heterologous recombination, as well as gene reassortments occur frequently during replication of retroviruses and most riboviruses, especially those that use enzymes with limited processivity. Following the generation of variant genomes, selection, which is dependent on environmental parameters in ways that are poorly understood, sorts out those genome fits enough to generate viable quasispecies. Chance events can also be destabilizing, as illustrated by recent results on fitness loss and other phenotypic changes accompanying bottleneck transmission. Variation, selection, and random sampling of genomes occur continuously and unavoidably during virus evolution. Evolution of RNA viruses is largely unpredictable because of the stochastic nature of mutation and recombination events, as well as the subtle effects of chance transmission events and host/environmental factors. Among environmental factors, alterations resulting from human intervention (deforestation, agricultural activities, global climatic changes, etc.) may alter dispersal patterns and provide new adaptive possibilities to viral quasispecies. Current understanding of RNA virus evolution suggests several strategies to control and diagnose viral diseases. The new generation of chemically defined vaccines and diagnostic reagents (monoclonal antibodies, peptide antigens, oligonucleotides for polymerase chain reaction amplification, etc.) may be adequate to prevent disease and detect some or even most of the circulating quasispecies of any given RNA pathogen. However, the dynamics of viral quasispecies mandate careful consideration of those reagents to be incorporated into diagnostic kits. Broadening diagnosis without jeopardizing specificity of detection will be challenging. There is a finite probability (impossible to quantify at present) that a defined vaccine may promote selection of escape mutants or a particular diagnostic kit may fail to detect a viral pathogen. Of particular concern are the potential long-term effects of weak selective pressures that may initially go unnoticed. Variant viruses resulting from evolutionary pressure imposed by vaccines or drugs may insidiously and gradually replace previous quasispecies. The great potential for variation and phenotypic diversity of some important RNA virus pathogens (human immunodeficiency virus, the hepatitis viruses, the newly recognized human hantaviruses, etc.) has become clear. Prevention and therapy should rely on multicomponent vaccines and antiviral agents to address the complexity of RNA quasispecies mutant spectra. This will require additional vaccine antigens and larger repertoires of drugs directed at multiple viral targets. Finally, new avenues of research, such as molecular approaches to promote error catastrophe during viral replication, should also be undertaken. Basic studies on quasispecies and on population genetics of RNA viruses are justified not only by their relevance to the understanding of viral evolution but also by their direct implications for viral pathogenesis and for strategies of disease control.",
keywords = "Diagnosis, Disease, Drug, Evolution, Quasispecies, RNA virus, Vaccine",
author = "Duarte, {E. A.} and Novella, {I. S.} and Scott Weaver and E. Domingo and S. Wain-Hobson and Clarke, {D. K.} and A. Moya and Elena, {S. F.} and {De la Torre}, {J. C.} and Holland, {J. J.}",
year = "1994",
language = "English",
volume = "3",
pages = "201--214",
journal = "Infectious Agents and Disease",
issn = "1056-2044",
publisher = "Raven Press",
number = "4",

}

TY - JOUR

T1 - RNA virus quasispecies

T2 - Significance for viral disease and epidemiology

AU - Duarte, E. A.

AU - Novella, I. S.

AU - Weaver, Scott

AU - Domingo, E.

AU - Wain-Hobson, S.

AU - Clarke, D. K.

AU - Moya, A.

AU - Elena, S. F.

AU - De la Torre, J. C.

AU - Holland, J. J.

PY - 1994

Y1 - 1994

N2 - The experimental evidence available for animal and plant RNA viruses, as well as other RNA genetic elements (viroids, satellites, retroelements, etc.), reinforces the view that many different types of genetic alterations may occur during RNA genome replication. This is fundamentally because of infidelity of genome replication and large population sizes. Homologous and heterologous recombination, as well as gene reassortments occur frequently during replication of retroviruses and most riboviruses, especially those that use enzymes with limited processivity. Following the generation of variant genomes, selection, which is dependent on environmental parameters in ways that are poorly understood, sorts out those genome fits enough to generate viable quasispecies. Chance events can also be destabilizing, as illustrated by recent results on fitness loss and other phenotypic changes accompanying bottleneck transmission. Variation, selection, and random sampling of genomes occur continuously and unavoidably during virus evolution. Evolution of RNA viruses is largely unpredictable because of the stochastic nature of mutation and recombination events, as well as the subtle effects of chance transmission events and host/environmental factors. Among environmental factors, alterations resulting from human intervention (deforestation, agricultural activities, global climatic changes, etc.) may alter dispersal patterns and provide new adaptive possibilities to viral quasispecies. Current understanding of RNA virus evolution suggests several strategies to control and diagnose viral diseases. The new generation of chemically defined vaccines and diagnostic reagents (monoclonal antibodies, peptide antigens, oligonucleotides for polymerase chain reaction amplification, etc.) may be adequate to prevent disease and detect some or even most of the circulating quasispecies of any given RNA pathogen. However, the dynamics of viral quasispecies mandate careful consideration of those reagents to be incorporated into diagnostic kits. Broadening diagnosis without jeopardizing specificity of detection will be challenging. There is a finite probability (impossible to quantify at present) that a defined vaccine may promote selection of escape mutants or a particular diagnostic kit may fail to detect a viral pathogen. Of particular concern are the potential long-term effects of weak selective pressures that may initially go unnoticed. Variant viruses resulting from evolutionary pressure imposed by vaccines or drugs may insidiously and gradually replace previous quasispecies. The great potential for variation and phenotypic diversity of some important RNA virus pathogens (human immunodeficiency virus, the hepatitis viruses, the newly recognized human hantaviruses, etc.) has become clear. Prevention and therapy should rely on multicomponent vaccines and antiviral agents to address the complexity of RNA quasispecies mutant spectra. This will require additional vaccine antigens and larger repertoires of drugs directed at multiple viral targets. Finally, new avenues of research, such as molecular approaches to promote error catastrophe during viral replication, should also be undertaken. Basic studies on quasispecies and on population genetics of RNA viruses are justified not only by their relevance to the understanding of viral evolution but also by their direct implications for viral pathogenesis and for strategies of disease control.

AB - The experimental evidence available for animal and plant RNA viruses, as well as other RNA genetic elements (viroids, satellites, retroelements, etc.), reinforces the view that many different types of genetic alterations may occur during RNA genome replication. This is fundamentally because of infidelity of genome replication and large population sizes. Homologous and heterologous recombination, as well as gene reassortments occur frequently during replication of retroviruses and most riboviruses, especially those that use enzymes with limited processivity. Following the generation of variant genomes, selection, which is dependent on environmental parameters in ways that are poorly understood, sorts out those genome fits enough to generate viable quasispecies. Chance events can also be destabilizing, as illustrated by recent results on fitness loss and other phenotypic changes accompanying bottleneck transmission. Variation, selection, and random sampling of genomes occur continuously and unavoidably during virus evolution. Evolution of RNA viruses is largely unpredictable because of the stochastic nature of mutation and recombination events, as well as the subtle effects of chance transmission events and host/environmental factors. Among environmental factors, alterations resulting from human intervention (deforestation, agricultural activities, global climatic changes, etc.) may alter dispersal patterns and provide new adaptive possibilities to viral quasispecies. Current understanding of RNA virus evolution suggests several strategies to control and diagnose viral diseases. The new generation of chemically defined vaccines and diagnostic reagents (monoclonal antibodies, peptide antigens, oligonucleotides for polymerase chain reaction amplification, etc.) may be adequate to prevent disease and detect some or even most of the circulating quasispecies of any given RNA pathogen. However, the dynamics of viral quasispecies mandate careful consideration of those reagents to be incorporated into diagnostic kits. Broadening diagnosis without jeopardizing specificity of detection will be challenging. There is a finite probability (impossible to quantify at present) that a defined vaccine may promote selection of escape mutants or a particular diagnostic kit may fail to detect a viral pathogen. Of particular concern are the potential long-term effects of weak selective pressures that may initially go unnoticed. Variant viruses resulting from evolutionary pressure imposed by vaccines or drugs may insidiously and gradually replace previous quasispecies. The great potential for variation and phenotypic diversity of some important RNA virus pathogens (human immunodeficiency virus, the hepatitis viruses, the newly recognized human hantaviruses, etc.) has become clear. Prevention and therapy should rely on multicomponent vaccines and antiviral agents to address the complexity of RNA quasispecies mutant spectra. This will require additional vaccine antigens and larger repertoires of drugs directed at multiple viral targets. Finally, new avenues of research, such as molecular approaches to promote error catastrophe during viral replication, should also be undertaken. Basic studies on quasispecies and on population genetics of RNA viruses are justified not only by their relevance to the understanding of viral evolution but also by their direct implications for viral pathogenesis and for strategies of disease control.

KW - Diagnosis

KW - Disease

KW - Drug

KW - Evolution

KW - Quasispecies

KW - RNA virus

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=0028050099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028050099&partnerID=8YFLogxK

M3 - Article

C2 - 7827789

AN - SCOPUS:0028050099

VL - 3

SP - 201

EP - 214

JO - Infectious Agents and Disease

JF - Infectious Agents and Disease

SN - 1056-2044

IS - 4

ER -